Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T.
Berger JR, et al.
Ann Neurol. 2010 Sep;68(3):409-11. doi: 10.1002/ana.22083.
Ann Neurol. 2010.
PMID: 20818795
No abstract available.